The routine use of PSA has been the subject of continued controversy owing to its limited specificity, which derives from the fact that elevated serum levels of PSA occur in a variety of non-neoplastic conditions such as prostatitis and benign prostate hyperplasia (BPH) [1]. This evidence concerns the gene KLK3 and urogenital neoplasm.